T cell activation and inhibition markers however were markedly elevated in patients with cirrhosis (HLA-DR; p<0.0001 and TIM-3; p = 0.0002) in comparison to HV (Fig. 1a). The gene discussed is HAVCR2; the disease is Cirrhosis.